Comments to FDA: Pilot Program to Evaluate Proposed Name Submissions

Share page:

Comments | Jul 7, 2008

Docket Number:

These comments are submitted in response to the public meeting held June 5 and 6, 2008, on evaluating proposed proprietary names for drug products.

Related Posts

Press Releases and Statements

CHPA Welcomes Three Consumer Healthcare Industry Members

Press Releases and Statements

CHPA Statement: OTC Pain Relievers and COVID-19 Vaccines